Clinical Trials Directory

Trials / Unknown

UnknownNCT01538082

Role of the Stress in the Development of the Metabolic Syndrome

Role of Anxiety, Depression, Quality of Life and Stressful Vital Events in the Development of the Metabolic Syndrome. StreX Project.

Status
Unknown
Phase
Study type
Observational
Enrollment
738 (estimated)
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is determine the incidence of metabolic syndrome (MetS) in people of high risk, of 40 or more years and attended in the Primary Care. Evaluating the association between anxiety, depression, quality of life and the vital stressful events, and the development of the metabolic syndrome in general population. Our hypothesis is that population of the cohort with bigger degree of stress will develop earlier the metabolic syndrome. If our hypothesis about the metabolic syndrome are demonstrated, it would allow establishing in a future interventions on these factors of risk to prevent or to decrease the incidence of this syndrome in the Primary Care.

Conditions

Timeline

Start date
2008-12-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-02-23
Last updated
2012-02-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01538082. Inclusion in this directory is not an endorsement.